EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers

Marliese Alexander iD, Chiao Xin Lim iD, Senthil Lingaratnam iD, Sarah Glewis iD, Joanne Wickens iD, Abbey Hird, Zi Yue Chen, Alistair Bozkurt iD, Amit Khot iD, David Routledge iD, Sam Harris, Craig Underhill iD und 10 weitere

Clinical and Translational Science · 2025

DOI: 10.1111/cts.70144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, 2025. Verfasst von Marliese Alexander und 21 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Neoplasms, Health Personnel, Pharmacogenetics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Integration of clinical pharmacogenomics (PGx) within routine cancer care is limited despite frequent use of medicines impacted by PGx, evidence for the benefits of PGx, and the availability of international PGx clinical guidelines. Our study objective was to develop survey tools to assess PGx knowledge, attitudes, practices, perceptions, and education needs among (a) doctors, nurses, and pharmacists involved in cancer care (healthcare professionals, HCPs) and (b) adults who have received cancer treatment or their carers (consumers), with the view to informing implementation strategies for PGx in solid and hematologic cancers. Survey tools were developed in a three‐phase (ph) mixed‐methods approach. Content was informed by systematic literature review findings and framed by determinants of behavior as informed by the Theoretical Domains Framework (ph‐1). Refinement occurred through four separate priority partnership meetings (ph‐2). Meetings focused on clinical PGx practices within select cancer streams, and consumers' knowledge, attitudes, and preferences for PGx testing. Content/face validity and health literacy (Flesch Kincaid Grade Level) assessments informed final refinements (ph‐3). Separate HCP and consumer survey tools were developed with six common sections: (1) introduction; (2) demographics; (3) experience; (4) knowledge, attitudes, practices and perceptions; (5) education; and (6) vignettes. Content and face validity were rated highly with acceptable health literacy assessments for questions within the consumer survey (median grade level 6; range 1–8). The developed survey tools will be used to generate evidence to inform local implementation strategies for PGx in cancer and promote broader integration of pharmacogenomics in routine clinical care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHealth PersonnelPharmacogeneticsHumansHealth Knowledge, Attitudes, PracticeSurveys and QuestionnairesAdultFemaleMaleHealth LiteracyMiddle AgedPharmacogenomic TestingAttitude of Health Personnel

Stichwörter der Autor:innen

cancerconsumershealth professionalspharmacogenomicssurvey

Autor:innen und Institutionen

  • Pharmacy Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Pharmacy, School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria, Australia.
  • Medicine Department, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
  • Clinical Haematology Department, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Bendigo Cancer Centre, Bendigo Health, Bendigo, Victoria, Australia.

ORCID-Profile: Marliese Alexander, Chiao Xin Lim, Senthil Lingaratnam, Sarah Glewis, Joanne Wickens, Alistair Bozkurt, Amit Khot, David Routledge, Craig Underhill, Ashley Whitechurch, Peter Savas, Safeera Y Hussainy

Zitieren

APA

Alexander, M., Lim, C. X., Lingaratnam, S., Glewis, S., Wickens, J., Hird, A., Chen, Z. Y., Bozkurt, A., Khot, A., Routledge, D., Harris, S., Underhill, C., Whitechurch, A., Leong, L., Pergolini, M., Rowan, G., Samo, M., Georgiou, C., Savas, P., …, & Hussainy, S. Y. (2025). Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers. Clinical and Translational Science. https://doi.org/10.1111/cts.70144

Vancouver

Alexander M, Lim CX, Lingaratnam S, Glewis S, Wickens J, Hird A, et al. Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers. Clinical and Translational Science. 2025. doi:10.1111/cts.70144

BibTeX
@article{Alexander2025,
  author = {Alexander, Marliese and Lim, Chiao Xin and Lingaratnam, Senthil and Glewis, Sarah and Wickens, Joanne and Hird, Abbey and Chen, Zi Yue and Bozkurt, Alistair and Khot, Amit and Routledge, David and Harris, Sam and Underhill, Craig and Whitechurch, Ashley and Leong, Lydia and Pergolini, Marcus and Rowan, Gail and Samo, Monnette and Georgiou, Chloe and Savas, Peter and Devine, Jenny and Kepert, Alysia and Hussainy, Safeera Y},
  title = {Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers},
  journal = {Clinical and Translational Science},
  year = {2025},
  doi = {10.1111/cts.70144}
}
Kostenlos starten →